|
US4010148A
(en)
|
1975-05-12 |
1977-03-01 |
Board Of Regents Of The University Of Texas System |
Purified thymosin and process
|
|
IL47645A
(en)
*
|
1975-07-04 |
1980-10-26 |
Yeda Res & Dev |
Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
|
|
JPS6030291B2
(ja)
*
|
1978-03-20 |
1985-07-16 |
森永乳業株式会社 |
人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
|
|
US4230697A
(en)
|
1978-07-03 |
1980-10-28 |
Morinaga Milk Industry Co. Ltd. |
Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same
|
|
US4624932A
(en)
*
|
1978-09-13 |
1986-11-25 |
Samuel Bogoch |
Recognins and their chemoreciprocals
|
|
DE2962521D1
(en)
*
|
1978-09-29 |
1982-05-27 |
Mitsubishi Chem Ind |
Process for the purification of long-chain acyl-coenzyme-a synthetase and the enzyme, acyl-coa synthetase, purified thereby
|
|
JPS5569595A
(en)
*
|
1978-11-20 |
1980-05-26 |
Suguru Abe |
Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation
|
|
CA1172980A
(en)
*
|
1979-04-02 |
1984-08-21 |
Kenji Takemoto |
Pentadecapeptide and process for the preparation thereof
|
|
DE3034529C2
(de)
*
|
1980-09-12 |
1982-09-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen |
Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel
|
|
DE3110560A1
(de)
*
|
1981-03-18 |
1982-10-14 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen |
"angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"
|
|
DE3110561A1
(de)
*
|
1981-03-18 |
1982-11-04 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen |
Chemorekrutine der leukozyten und des entszuendungsgewebes: eine neue klasse natuerlicher leukopoetine zurselektiven chemorekrutierung von leukozyten aus dem knochenmark in den blutstrom (leukozytose- und linskverschiebungsreaktion)
|
|
US4532207A
(en)
*
|
1982-03-19 |
1985-07-30 |
G. D. Searle & Co. |
Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
|
|
US4390468A
(en)
|
1982-08-04 |
1983-06-28 |
Maruzen Oil Co., Ltd. |
Preparation of antitumor agent from shellfish
|
|
US4882421A
(en)
|
1982-09-23 |
1989-11-21 |
Alfacell Corporation |
Pharmaceutical for treating tumors and method for making it
|
|
US4568545A
(en)
|
1982-10-02 |
1986-02-04 |
Amano Seiyaku Kabushiki Kaisha |
Thrombolytic agent
|
|
JPS5980613A
(ja)
*
|
1982-10-29 |
1984-05-10 |
Mitsui Toatsu Chem Inc |
新規なプラスミノ−ゲン・アクチベ−タ及びその製造方法
|
|
US4880914A
(en)
*
|
1982-11-09 |
1989-11-14 |
Cornell Research Foundation, Inc. |
Assay for qualitatively and/or quantitatively measuring hLH or hCG in body fluids and reagents therefor
|
|
US4966888A
(en)
|
1985-07-08 |
1990-10-30 |
Cornell Research Foundation, Inc. |
hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine
|
|
US4639513A
(en)
|
1984-02-02 |
1987-01-27 |
Cuno Inc. |
Intravenously injectable immunoglobulin G (IGG) and method for producing same
|
|
GB8314362D0
(en)
|
1983-05-24 |
1983-06-29 |
Celltech Ltd |
Polypeptide and protein products
|
|
US4456676A
(en)
*
|
1983-06-10 |
1984-06-26 |
E. I. Du Pont De Nemours And Company |
Amine stabilizers for wash-off systems
|
|
US4444760A
(en)
*
|
1983-06-17 |
1984-04-24 |
Merck & Co., Inc. |
Purification and characterization of a protein fibroblast growth factor
|
|
JPS6028999A
(ja)
*
|
1983-06-30 |
1985-02-14 |
Maruho Kk |
細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
|
|
JPH0794473B2
(ja)
*
|
1984-03-02 |
1995-10-11 |
サントリー株式会社 |
新規なペプチド及びこれを有効成分とする利尿剤
|
|
JPS60184098A
(ja)
*
|
1984-03-02 |
1985-09-19 |
Suntory Ltd |
新規なペプチド及びこれを有効成分とする利尿剤
|
|
US4670539A
(en)
*
|
1984-07-27 |
1987-06-02 |
Board Of Regents, The University Of Texas |
Peptide growth factors derived from estrogen responsive kidney tissue
|
|
US5132214A
(en)
*
|
1986-04-09 |
1992-07-21 |
Monsanto Company |
Large scale production of plasminogen activator from normal human colon cells
|
|
US5030559A
(en)
*
|
1986-04-01 |
1991-07-09 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the identification of metastatic human tumors
|
|
US5213970A
(en)
|
1987-01-23 |
1993-05-25 |
Board Of Regents, The University Of Texas System |
Method for obtaining soluble antitumor factor
|
|
US5162507A
(en)
*
|
1987-05-11 |
1992-11-10 |
Cetus Corporation |
Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
|
|
DE3877529T2
(de)
|
1987-10-23 |
1996-11-07 |
Centre Regional De Transfusion |
Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
|
|
JPH01238534A
(ja)
|
1988-03-17 |
1989-09-22 |
Mitsui Toatsu Chem Inc |
エンドトキシンの除去方法
|
|
US5760183A
(en)
|
1989-02-17 |
1998-06-02 |
Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques |
Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
|
|
DE3914354C1
(es)
*
|
1989-04-29 |
1990-10-31 |
Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De |
|
|
DK165090D0
(da)
|
1990-07-09 |
1990-07-09 |
Kem En Tec As |
Konglomererede partikler
|
|
FR2676231A1
(fr)
*
|
1991-05-07 |
1992-11-13 |
Aetsrn |
Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
|
|
JPH0518950A
(ja)
|
1991-07-09 |
1993-01-26 |
Showa Denko Kk |
アフイニテイクロマトグラフイー用吸着担体
|
|
DK0547544T3
(da)
|
1991-12-18 |
1997-09-08 |
Hoechst Ag |
Fremgangsmåde til fremstilling af insulinholdige opløsninger.
|
|
US5372942A
(en)
|
1992-02-10 |
1994-12-13 |
Coriell Institute For Medical Research |
Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
|
|
CH685498A5
(fr)
*
|
1992-02-14 |
1995-07-31 |
Om Lab Sa |
Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
|
|
JP2767521B2
(ja)
|
1992-09-04 |
1998-06-18 |
農林水産省食品総合研究所長 |
新規抗腫瘍性蛋白質とその製造法および該蛋白質を有効成分として含有する抗腫瘍剤
|
|
DE69424687T2
(de)
*
|
1993-03-09 |
2000-09-07 |
Genzyme Corp., Cambridge |
Verfahren zur isolierung von proteinen aus milch
|
|
US5710126A
(en)
*
|
1993-03-12 |
1998-01-20 |
Immulogic Pharmaceutical Corporation |
T cell epitopes of ryegrass pollen allergen
|
|
US6607884B1
(en)
*
|
1993-03-19 |
2003-08-19 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-8
|
|
US5332503A
(en)
*
|
1993-04-16 |
1994-07-26 |
Baxter International Inc. |
Process for purifying collagenase
|
|
US5330972A
(en)
*
|
1993-05-28 |
1994-07-19 |
Abbott Laboratories |
Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
|
|
JP2971293B2
(ja)
*
|
1993-06-11 |
1999-11-02 |
株式会社細菌化学研究所 |
溶血性連鎖球菌の産生する生理活性物質及びその製造法
|
|
US5500413A
(en)
*
|
1993-06-29 |
1996-03-19 |
Ferring Ab |
Process for manufacture of 1-deamino-8-D-arginine vasopressin
|
|
US5478924A
(en)
*
|
1994-02-16 |
1995-12-26 |
Cramer; Steven M. |
Displacement chromatography of proteins using low molecular weight displacers
|
|
US5570389A
(en)
*
|
1994-06-30 |
1996-10-29 |
Compaq Computer Corporation |
Method for reliable exchange of modem handshaking information over a cellular radio carrier
|
|
US5659017A
(en)
|
1995-11-07 |
1997-08-19 |
Alpha Therapeutic Corporation |
Anion exchange process for the purification of Factor VIII
|
|
DE19600939C1
(de)
*
|
1996-01-12 |
1997-08-28 |
Immuno Ag |
Verfahren zur Trennung von IgG und IgA
|
|
SE9603068D0
(sv)
*
|
1996-08-23 |
1996-08-23 |
Pharmacia & Upjohn Ab |
Process for purifying a protein
|
|
EP0950067B1
(en)
*
|
1996-11-27 |
2007-08-29 |
Genentech, Inc. |
Affinity purification of polypeptide on protein a matrix
|
|
ZA9711580B
(en)
*
|
1996-12-25 |
1999-09-23 |
Hoechst Marion Roussel Ltd |
Process for the production of purified dimeric bone morphogenetic factors.
|
|
GB9717953D0
(en)
*
|
1997-08-22 |
1997-10-29 |
Smithkline Beecham Biolog |
Vaccine
|
|
US6451260B1
(en)
|
1997-08-26 |
2002-09-17 |
Dyax Corp. |
Method for producing microporous elements, the microporous elements thus produced and uses thereof
|
|
US20030036629A1
(en)
*
|
1997-12-12 |
2003-02-20 |
Barry Foster |
Novel tgf-beta protein purification methods
|
|
US6673629B2
(en)
*
|
1998-01-15 |
2004-01-06 |
Abbott Laboratories |
Neutralization of polycations in a chromatographic device for whole blood use
|
|
DE19937219A1
(de)
|
1999-08-06 |
2001-02-08 |
Aventis Behring Gmbh |
Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie
|
|
WO1999061464A1
(en)
*
|
1998-05-28 |
1999-12-02 |
Korea Green Cross Corporation |
Process of purifying angiogenesis inhibitors
|
|
DK2270044T3
(en)
*
|
1998-06-09 |
2015-01-26 |
Csl Behring Ag |
Liquid immunoglobulin G (IgG) product
|
|
GB9815666D0
(en)
*
|
1998-07-17 |
1998-09-16 |
Smithkline Beecham Plc |
Novel compounds
|
|
RU2143492C1
(ru)
|
1998-07-23 |
1999-12-27 |
Навашин Петр Сергеевич |
Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека
|
|
RU2144082C1
(ru)
|
1998-07-23 |
2000-01-10 |
Навашин Петр Сергеевич |
Рекомбинантная плазмида, кодирующая гибридный белок-предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка-предшественника инсулина человека (варианты) и способ получения инсулина человека
|
|
US7300753B2
(en)
*
|
1998-09-04 |
2007-11-27 |
John Rush |
Immunoaffinity isolation of modified peptides from complex mixtures
|
|
US7198896B2
(en)
*
|
1998-09-04 |
2007-04-03 |
Cell Signaling Technology, Inc. |
Immunoaffinity isolation of modified peptides from complex mixtures
|
|
US6939545B2
(en)
|
1999-04-28 |
2005-09-06 |
Genetics Institute, Llc |
Composition and method for treating inflammatory disorders
|
|
US7307161B1
(en)
*
|
1999-04-28 |
2007-12-11 |
Genetics Institute, Llc |
Human Gil-19/AE289 polynucleotides
|
|
DE19937218A1
(de)
*
|
1999-08-06 |
2001-02-08 |
Aventis Behring Gmbh |
Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
|
|
US6774102B1
(en)
|
1999-09-29 |
2004-08-10 |
Gambro Dialysatoren Gmbh & Co. Kg |
Extracorporeal endotoxin removal method
|
|
WO2001032915A2
(en)
*
|
1999-11-04 |
2001-05-10 |
Genentech, Inc. |
Reversed-phase hplc assay for plasminogen activators
|
|
US6825164B1
(en)
*
|
2000-08-14 |
2004-11-30 |
The Trustees Of Columbia University In The City Of New York |
Method to increase cerebral blood flow in amyloid angiopathy
|
|
DE10046960A1
(de)
*
|
2000-09-22 |
2002-04-11 |
Roche Diagnostics Gmbh |
Verfahren zur Herstellung einer aktiven, heterodimeren AMW-RT in prokaryotischen Zellen
|
|
US20030133939A1
(en)
*
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7754208B2
(en)
*
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7638604B2
(en)
|
2001-02-23 |
2009-12-29 |
Genetics Institute, Llc |
Monoclonal antibodies against interleukin-22
|
|
US20040058445A1
(en)
*
|
2001-04-26 |
2004-03-25 |
Ledbetter Jeffrey Alan |
Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB
|
|
DE60213248T2
(de)
*
|
2001-06-05 |
2006-11-30 |
Genetics Institute, LLC, Cambridge |
Verfahren zur reinigung hochanionischer proteine
|
|
WO2003031471A1
(en)
*
|
2001-10-09 |
2003-04-17 |
The Government Of The United States Of America, As Represented By The Department Of Health And Human Services |
Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb)
|
|
US20040161776A1
(en)
*
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
WO2003066669A2
(en)
*
|
2002-02-04 |
2003-08-14 |
Millipore Corporation |
Process for removing protein aggregates and virus from a protein solution
|
|
AU2003210802B2
(en)
*
|
2002-02-05 |
2009-09-10 |
Genentech Inc. |
Protein purification
|
|
WO2004000220A2
(en)
*
|
2002-06-21 |
2003-12-31 |
Genetix Pharmaceuticals, Inc. |
Methods for purifying viral particles for gene therapy
|
|
AR047392A1
(es)
|
2002-10-22 |
2006-01-18 |
Wyeth Corp |
Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
|
|
EP2336172B1
(en)
*
|
2003-10-27 |
2014-12-10 |
Wyeth LLC |
Removal of high molecular weight aggregates using hydroxyapatite chromatography
|
|
US7065110B2
(en)
*
|
2004-01-20 |
2006-06-20 |
Northrop Grumman Corporation |
Scalable wavelength shifted laser source and method
|
|
US8084032B2
(en)
*
|
2004-01-21 |
2011-12-27 |
Ajinomoto Co., Inc. |
Purification method which prevents denaturation of an antibody
|
|
US7501121B2
(en)
*
|
2004-06-17 |
2009-03-10 |
Wyeth |
IL-13 binding agents
|
|
AR049390A1
(es)
*
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
|
AU2006223180B2
(en)
*
|
2005-03-11 |
2011-11-24 |
Wyeth Llc |
A method of weak partitioning chromatography
|